Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 343 followers
Latest posts
Last updated about 1 hour ago
Pfizer offloads scrapped Seagen ADC to Medicus Pharma in up to $1B+ deal
about 1 hour ago
Pfizer has found a new home for an antibody-drug conjugate it acquired...
Why Roche is 'really excited' about a UCN2 analog for obesity after seeing preclinical data
about 3 hours ago
Roche has decided to pay $190 million upfront for an unusual obesity...
AbbVie’s bispecific T-cell engager shows promise in ph. 3 multiple myeloma trial
about 4 hours ago
AbbVie released positive phase 3 data Thursday showing that its bispecific T-cell...
GSK pens $1.3B Hutchmed deal for early-stage KRAS-EGFR cancer asset
about 6 hours ago
GSK is handing over $110 million upfront to Hutchmed in a deal...
Ultragenyx fails phase 3 Angelman test, plots ‘significant expense reductions’
about 6 hours ago
Ultragenyx had been flying high after its recent FDA approval for Genglycos—but...
Fortrea boosts early-phase CRO platform with $45M acquisition of Worldwide division
about 22 hours ago
Fortrea has agreed to acquire the early-phase services division of fellow CRO...
Novartis telegraphs 130 job cuts amid biologics rethink in Switzerland
about 23 hours ago
Novartis could cut about 130 jobs in Switzerland as it rethinks its...
Teva autoimmune antibody notches ph. 2 win in celiac disease
1 day ago
Teva Pharmaceutical's dreams of a first-in-class autoimmune blockbuster are being kept alive...
TScan axes 75% of workforce to make room for solid tumor programs
1 day ago
TCR-T specialist TScan Therapeutics will reduce its workforce by 75% following the...
SEC, FDA sign info-sharing agreement as a ‘signal to the market’ on insider trading
1 day ago
The SEC and the FDA have signed a three-year agreement to step...
Novartis inks $3.2B subcutaneous drug delivery deal with Alteogen
1 day ago
Novartis has struck a deal worth up to $3.2 billion to work...
From his parents’ basement to your medicine cabinet: Absci CEO endeavors to create biotech’s Apple
1 day ago
The overwhelming demand for GLP-1 weight loss drugs has reshaped the drug...